Natera, Inc.
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Stock Options Outstanding by Quarter
Stock Options Outstanding — Aggregate Intrinsic Value ($M) ($M)
Natera Stock Options Outstanding: $725M in Q4 2025, up 46.2% from a year earlier. That is the highest of the 27 quarters on record here.
Latest, Q4 2025
725
Period ended Dec 31, 2025
Change on a year earlier
+46.2%
496 in Q4 2024
History
27 quarters
Since Q4 2017
Sources
26
Documents cited below
Where the Q4 2025 figure comes from
Source: Form 10-K (2026-02-27) ↗
Reported in Form 10-K Note — Stock-Based Compensation (XBRL).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Stock Options Outstanding — Aggregate Intrinsic Value ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2025 | Dec 31, 2025 | 725 | +46.2% | Form 10-K (2026-02-27) ↗ |
| Q4 2024 | Dec 31, 2024 | 496 | +114.7% | Form 10-K (2026-02-27) ↗ |
| Q4 2023 | Dec 31, 2023 | 231 | +75.9% | Form 10-K (2025-02-28) ↗ |
| Q3 2023 | Sep 30, 2023 | 143 | -4.9% | Form 10-Q (2023-11-09) ↗ |
| Q2 2023 | Jun 30, 2023 | 165 | +47.0% | Form 10-Q (2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 200 | +43.0% | Form 10-Q (2023-05-10) ↗ |
| Q4 2022 | Dec 31, 2022 | 131 | -70.9% | Form 10-K (2024-02-29) ↗ |
| Q3 2022 | Sep 30, 2022 | 150 | -73.6% | Form 10-Q (2022-11-09) ↗ |
| Q2 2022 | Jun 30, 2022 | 112 | -81.5% | Form 10-Q (2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 140 | -74.6% | Form 10-Q (2022-05-06) ↗ |
| Q4 2021 | Dec 31, 2021 | 452 | -23.8% | Form 10-K (2023-03-01) ↗ |
| Q3 2021 | Sep 30, 2021 | 567 | +28.3% | Form 10-Q (2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | 606 | +100.7% | Form 10-Q (2021-08-06) ↗ |
| Q1 2021 | Mar 31, 2021 | 551 | +244.2% | Form 10-Q (2021-05-07) ↗ |
| Q4 2020 | Dec 31, 2020 | 592 | +199.3% | Form 10-K (2022-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 442 | +123.0% | Form 10-Q (2020-11-06) ↗ |
| Q2 2020 | Jun 30, 2020 | 302 | +81.6% | Form 10-Q (2020-08-07) ↗ |
| Q1 2020 | Mar 31, 2020 | 160 | +48.3% | Form 10-Q (2020-05-08) ↗ |
| Q4 2019 | Dec 31, 2019 | 198 | +220.7% | Form 10-K (2021-02-26) ↗ |
| Q3 2019 | Sep 30, 2019 | 198 | +30.5% | Form 10-Q (2019-11-08) ↗ |
| Q2 2019 | Jun 30, 2019 | 166 | +35.9% | Form 10-Q (2019-08-09) ↗ |
| Q1 2019 | Mar 31, 2019 | 108 | +229.1% | Form 10-Q (2019-05-10) ↗ |
| Q4 2018 | Dec 31, 2018 | 61.7 | +93.5% | Form 10-K (2020-03-02) ↗ |
| Q3 2018 | Sep 30, 2018 | 152 | – | Form 10-Q (2018-11-09) ↗ |
| Q2 2018 | Jun 30, 2018 | 122 | – | Form 10-Q (2018-08-09) ↗ |
| Q1 2018 | Mar 31, 2018 | 32.8 | – | Form 10-Q (2018-03-31) ↗ |
| Q4 2017 | Dec 31, 2017 | 31.9 | – | Form 10-K (2019-03-15) ↗ |
Cite this data
StockData. (2026). Natera Stock Options Outstanding ($M), quarterly Q4 2017–Q4 2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/equity-options-outstanding-intrinsic-val
See every metric in the Natera KPI table. Data updated Nov 2, 2026.